Abstract Background: The development of liver diseases adversely affects global health, emerging as a prominent cause of mortality globally and imposing a significant economic strain on society
The findings were published in Biochemical and Biophysical Research Communications under the title describing a tripeptide in human serum that prolongs survival of normal liver cells and stimulates growth in neoplastic liver tissue, marking the formal entry of GHK-Cu into the scientific literature
The study was approved by the local research ethics committee with approval code (No: 36264MS83/2/23)
That, in turn, decreased the production of toxic alcohol metabolites in experimental models
In fact, for patients at New Jersey Bariatric Center, the path to lasting results isn't a single choice
Key Takeaways Same receptor, different worlds of evidence